Pro Nephro AKI (NGAL) is now FDA-Cleared     READ MORE

An ELISA for the in vitro determination of human NGAL in urine, serum, plasma, tissue extracts or culture media.

NGAL ELISA Kit (human)

CAT NO: KIT 036


Cat. No.

KIT 036

Assay range

10-1000 pg/mL

Assay time

4 hours

Limit of detection

4 pg/mL

Sample dilution

1/500 (Urine from healthy subjects)

Species reactivity (positive)

None

Storage

4°C

Target

Human NGAL (Neutrophil Gelatinase-Associated Lipocalin)

Background

NGAL is a new early biomarker for diagnosing acute kidney injury (AKI). Under normal conditions, NGAL levels are low in urine and plasma, but they rise sharply from basal levels in response to kidney injury to reach diagnostic levels within a very short time - as much as 24 hours or more before any significant rise in serum creatinine.

Regulatory status

RUO - Research Use Only

Patent status

This product is protected by one or more US, European and/or foreign patents.